Aug 01, 2022 / 12:30PM GMT
Operator
Good day, and thank you for standing by. Welcome to the Arcutis Biotherapeutics FDA Approval Conference Call. (Operator Instructions). Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Mr. Eric McIntyre, Head of Investor Relations. Mr. McIntyre. Please go ahead.
Eric McIntyre - Arcutis Biotherapeutics, Inc. - Head of IR
Thank you, Chris. Good morning, everyone, and thank you for joining. As you can imagine, we're all incredibly proud and excited to be here with you this morning to discuss the FDA approval of ZORYVE for plaque psoriasis.
Just a couple of logistical details before we get started. Today's webcast and posted presentation can be found under the Events and Presentations tab of our Investors section of our website. And then just a reminder to everyone that the safe harbor rules govern our remarks today and as well as any forward-looking statements that we may make during this call. These statements are subject to any risks and uncertainties that could
Arcutis Biotherapeutics Inc FDA Approval Conference Call Transcript
Aug 01, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers